KCT0001284
Recruiting
未知
Comparison of propofol, dexamedetomidine and their combination’s effect for sedation
Hanyang University Seoul Hospital0 sites90 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hanyang University Seoul Hospital
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients who reqiure Brachial plexus block.
- •American Society of Anesthesiologists’ classification from 1 to 3\.
Exclusion Criteria
- •patients whe do not agree with the experiment.
- •Patients with impaired cognitive function.
- •Patients with serious neurological, cardiac, liver, and kidney disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Comparative effect of propofol and dexmedetomidine on fertility rate in patients candidate for IVFinfertility.N97. 9IRCT20190121042444N2Shahid Beheshti University of Medical Sciences78
Recruiting
Not Applicable
Comparison effect of propofol and Dexmedetomidine in hemodynamic ?response in emergency intubatioIRCT2016102520258N14Vice chancellor for research, Arak University of Medical Sciences114
Recruiting
Phase 2
Comparison of the Effectiveness of dexmedetomidine and propofol in electrochemotherapy of breast cancer skin lesioIRCT20240515061805N1Shahid Beheshti University of Medical Sciences36
Completed
Phase 2
Comparison of two medications in reducing blood pressure and bleeding in sinus surgeryChronic sinusitis.Chronic sinusitisIRCT2015101814056N5Arak University of Medical Sciences, Vice Chancellor for Research100
Not yet recruiting
Not Applicable
Comparison of the effect of propofol vs dexmedetomidine sedation on NIHSS score (National institute of health stroke scale) and SSEP(somatosensory evoked potential ) in patients for supratentorial tumors.Health Condition 1: C713- Malignant neoplasm of parietal lobeHealth Condition 2: C713- Malignant neoplasm of parietal lobeHealth Condition 3: C712- Malignant neoplasm of temporal lobeCTRI/2022/02/040164Sree Chitra Tirunal institute of Medical sciences and technology